These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22808022)

  • 1. Acute HCV/HIV coinfection is associated with cognitive dysfunction and cerebral metabolite disturbance, but not increased microglial cell activation.
    Garvey LJ; Pavese N; Ramlackhansingh A; Thomson E; Allsop JM; Politis M; Kulasegaram R; Main J; Brooks DJ; Taylor-Robinson SD; Winston A
    PLoS One; 2012; 7(7):e38980. PubMed ID: 22808022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the variability of cerebral proton magnetic resonance spectroscopy (1H-MRS) measurements within three HIV-infected cohorts.
    Vigneswaran S; Rojas JH; Garvey L; Taylor-Robinson S; Winston A
    Neuroradiol J; 2015 Dec; 28(6):545-54. PubMed ID: 26493269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapy.
    Winston A; Duncombe C; Li PC; Gill JM; Kerr SJ; Puls RL; Taylor-Robinson SD; Emery S; Cooper DA;
    Neuroradiology; 2012 Dec; 54(12):1331-9. PubMed ID: 22772471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does acute hepatitis C infection affect the central nervous system in HIV-1 infected individuals?
    Winston A; Garvey L; Scotney E; Yerrakalva D; Allsop JM; Thomson EC; Grover VP; Main J; Cox JI; Wylezinska M; Taylor-Robinson SD
    J Viral Hepat; 2010 Jun; 17(6):419-26. PubMed ID: 19780944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition.
    Byrnes V; Miller A; Lowry D; Hill E; Weinstein C; Alsop D; Lenkinski R; Afdhal NH
    J Hepatol; 2012 Mar; 56(3):549-56. PubMed ID: 22027578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: magnetic resonance spectroscopy and immunologic correlation.
    Bladowska J; Zimny A; Kołtowska A; Szewczyk P; Knysz B; Gąsiorowski J; Furdal M; Sąsiadek MJ
    Eur J Radiol; 2013 Apr; 82(4):686-92. PubMed ID: 23246331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral immune activation in chronic hepatitis C infection: a magnetic resonance spectroscopy study.
    Forton DM; Hamilton G; Allsop JM; Grover VP; Wesnes K; O'Sullivan C; Thomas HC; Taylor-Robinson SD
    J Hepatol; 2008 Sep; 49(3):316-22. PubMed ID: 18538439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of hepatic FOXP3+ T-lymphocytes in HIV/hepatitis C coinfection.
    Williams SK; Donaldson E; Van der Kleij T; Dixon L; Fisher M; Tibble J; Gilleece Y; Klenerman P; Banham AH; Howard M; Webster DP
    J Viral Hepat; 2014 Apr; 21(4):251-9. PubMed ID: 24597693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnitude of [(11)C]PK11195 binding is related to severity of motor deficits in a rabbit model of cerebral palsy induced by intrauterine endotoxin exposure.
    Kannan S; Saadani-Makki F; Balakrishnan B; Chakraborty P; Janisse J; Lu X; Muzik O; Romero R; Chugani DC
    Dev Neurosci; 2011; 33(3-4):231-40. PubMed ID: 21791891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography imaging of peripheral benzodiazepine receptor binding in human immunodeficiency virus-infected subjects with and without cognitive impairment.
    Wiley CA; Lopresti BJ; Becker JT; Boada F; Lopez OL; Mellors J; Meltzer CC; Wisniewski SR; Mathis CA
    J Neurovirol; 2006 Aug; 12(4):262-71. PubMed ID: 16966217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volume, metabolites and neuroinflammation of the hippocampus in bipolar disorder - A combined magnetic resonance imaging and positron emission tomography study.
    Haarman BC; Burger H; Doorduin J; Renken RJ; Sibeijn-Kuiper AJ; Marsman JB; de Vries EF; de Groot JC; Drexhage HA; Mendes R; Nolen WA; Riemersma-Van der Lek RF
    Brain Behav Immun; 2016 Aug; 56():21-33. PubMed ID: 26348581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive impairment with hepatitis C and HIV co-infection in Southern Brazil.
    de Almeida SM; de Pereira AP; Pedroso MLA; Ribeiro CE; Rotta I; Tang B; Umlauf A; Franklin D; Saloner RG; Batista MGR; Letendre S; Heaton RK; Ellis RJ; Cherner M;
    J Neurovirol; 2018 Jun; 24(3):339-349. PubMed ID: 29516346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammation.
    Grover VP; Pavese N; Koh SB; Wylezinska M; Saxby BK; Gerhard A; Forton DM; Brooks DJ; Thomas HC; Taylor-Robinson SD
    J Viral Hepat; 2012 Feb; 19(2):e89-96. PubMed ID: 22239531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of CD4⁺ T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patients.
    Hodowanec AC; Brady KE; Gao W; Kincaid SL; Plants J; Bahk M; Landay AL; Huhn GD
    J Acquir Immune Defic Syndr; 2013 Nov; 64(3):232-40. PubMed ID: 24131865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients.
    Ma Q; Vaida F; Wong J; Sanders CA; Kao YT; Croteau D; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; Morgello S; Simpson DM; Heaton RK; Grant I; Letendre SL;
    J Neurovirol; 2016 Apr; 22(2):170-8. PubMed ID: 26407716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of human immune deficiency virus and hepatitis C coinfection on white matter microstructural integrity.
    Heaps-Woodruff JM; Wright PW; Ances BM; Clifford D; Paul RH
    J Neurovirol; 2016 Jun; 22(3):389-99. PubMed ID: 26689572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes.
    Cohen RA; Harezlak J; Gongvatana A; Buchthal S; Schifitto G; Clark U; Paul R; Taylor M; Thompson P; Tate D; Alger J; Brown M; Zhong J; Campbell T; Singer E; Daar E; McMahon D; Tso Y; Yiannoutsos CT; Navia B;
    J Neurovirol; 2010 Nov; 16(6):435-44. PubMed ID: 20961212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects.
    Papasavvas E; Azzoni L; Yin X; Liu Q; Joseph J; Mackiewicz A; Ross B; Lynn KM; Jacobson JM; Mounzer K; Kostman JR; Montaner LJ
    J Viral Hepat; 2017 Oct; 24(10):865-876. PubMed ID: 28419653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naïve HIV patients.
    Chang L; Ernst T; Witt MD; Ames N; Gaiefsky M; Miller E
    Neuroimage; 2002 Nov; 17(3):1638-48. PubMed ID: 12414302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.